Genomill

New IP! US grant number: US11898202. #getitpatented with @MoosedogIPR Stay tuned for more news!

Genomill, Finland's iCAN Partner to Improve Geno1 Cancer Detection With Biobank Samples. The molecular diagnostic firm will use iCAN's database of genomic and clinical data to help improve the sensitivity of its liquid biopsy technology. ow.ly/664e104Kpub

Exciting iCAN Impact event kicking off at ⁦@terkko⁩ with Alexandra and ⁦@science_yall⁩ - few seats and pizza & beer available!@vincersurf⁩ ⁦@UH_Innovation⁩ ⁦@FIMM_UH⁩ ⁦@HUS_fi⁩ ⁦@HelsinkiUniMed⁩ ⁦@HiLIFE_helsinki⁩ ⁦@genomill⁩

We are thrilled to announce partnership with Genomill aiming to improve the detection of trace tumour DNA from thousands of biobank samples! ican.fi/genomill-and-f… #PressRelease @HelsinkiUniMed @genomill @tomakela @UH_Innovation

⁦@genomill⁩ CEO Kalle Koskinen with great hints on starting up in liquid biopsy business. Collaboration with iCAN starting today! ⁦@helsinkiuni⁩ ⁦@HUS_fi⁩ ⁦@SuomenAkatemia⁩

@illumina @fdesouza Be bold and ambitious!

“In this room, we have some of the world's most brilliant minds.” - @Fdesouza kicking off #IGF 2022

prnewswire.co.uk/news-releases/… #geno1 #bridgecapture #liquidbiosies #ngs #precisiondiagnostics #PMWC22

Proud to live in a country where the President himself is such a strong supporter of the startup community! Means a lot. Thank you @niinisto !

Lämmin kiitos presidentti ⁦⁦@niinisto⁩ tervehdyksestänne ⁦@startupyhteiso⁩ ensimmäiseen juhlagaalaan, joka vietettiin perjantaina. Yli satapäinen juhlayleisö arvosti sanojanne todella kovasti. startupyhteiso.com/en/blog/messag…

@BillionToOneInc Congrats!

We always strive for quality and precision in our @BillionToOneInc laboratory, so being CAP accredited and CLIA certified supports these critical priorities.

“We are grateful and proud of Finnish society and the welfare state. It has laid the groundwork for our success. It’s why we are here. We have joined @startupyhteiso with 100 other Finnish startups to ensure the future generations have the opportunity as well.

@ForesiteCapital @WSJVC This is of high interest to us @genomill - and great news for genomics.

So thankful for the comprehensive coverage of our most recent fundraise. A tip of our hat to the @WSJVC for this story.

Venture investor Foresite closed two new funds to invest in sectors such as biotechnology and genomics wsj.com/articles/life-…

@ForesiteCapital @Manasmishra24 @Reuters Sounds interesting!

We’re excited to announce our largest fundraise to date, with $969 million in capital commitments to invest in companies that are transforming healthcare. Read more from @Manasmishra24 in @Reuters here: reuters.com/article/foresi… #healthcare #venturecapital #biotech

@GrailBio 💎

We are pleased to announce GRAIL, the NHS, and the UK Government are partnering to transform cancer outcomes with the Galleri multi-cancer early detection blood test bit.ly/369ZdWA

This confirms that we are on the right path with our disruptive ligation-based Geno1 technology. One of the biggest players is taking the steps for cheaper,more precise and faster tests. #Genomill #Geno1 #liquidbiopsy #impact #stayintune genomeweb.com/business-news/…

Our disruptive technology #Geno1 is running ahead of the schedule. #Genomill #liquidbiopsy #stayintune #diagnostics #oncology

@arctic15 Stockholm - ”An investment in knowledge pays the best interest” (Benjamin Franklin)